DNA methylation is involved in regulation of PR-signaling in endometriosis.
This study investigated the role of progesterone receptor signaling in endometriosis using an immunocompetent mouse model where lesions were induced and maintained with estradiol. Researchers treated these mice with decitabine, a DNA methyltransferase inhibitor, to determine if DNA methylation regulates progesterone resistance within ectopic endometrial tissues. The findings demonstrated that inhibiting DNA methylation restored progesterone receptor expression and alleviated lesion growth by suppressing cell proliferation, inflammation, and angiogenesis. This paper is centrally about endometriosis, specifically focusing on the molecular mechanisms of progesterone resistance driven by DNA methylation in ectopic lesions.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Abstract
Full text
1,256 characters
· extracted from
oa-doi-fallback
· click to expand
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Condition tags
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- openalex
- last seen: 2026-05-11T08:39:19.672494+00:00